报价延迟最少15分钟:2025/09/16 23:16 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.79 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.29/-0.24
|
|
企业价值
262.25M
|
| 资产负债 |
|
每股账面净值
0.02
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
26.92M
|
|
每股收益
0.32
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/09/16 23:16 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, andinformation solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream. |
